Almac Pharma Services are extending their formulation facilities with the opening of a refurbished 10,500-sq.-ft. building at the company’s UK headquarters. The company invested $10.5 million to strengthen its offering to the global pharma and biopharma industries. The custom-designed facility will operate to full cGMP, providing extended formulation development services in solid oral dosage forms from pre-clinical through to pilot scale. This advancement will provide classified facilities ...